MoleMap

What MoleMap does

MoleMap is a New Zealand-founded private medical practice company specializing in skin cancer detection, proactive monitoring, and diagnosis, established in 1996 and headquartered in Auckland with operations across New Zealand and Australia. The company operates a multi-tiered clinical service platform — Full Body MoleMap (comprehensive head-to-toe skin check with full body photography and ongoing monitoring, ~50 minutes), SkinCheck+ (mid-tier check with full body imaging, ~20-30 minutes), and SkinCheck (point-in-time assessment, ~15-20 minutes) — all delivered through a proprietary "triple-check" model combining registered-nurse melanographers, a custom-built AI diagnostic tool cross-referenced against a 30-year image database of 13M+ moles, and accredited dermatologist diagnosis. Services extend to skin cancer treatment (topical therapy, cryotherapy, surgery), workplace onsite screening programs for enterprise customers, and a fast-tracked GP referral pathway.

The company generates revenue through pay-as-you-go professional service fees across its service tiers, supplemented by enterprise workplace contracts and insurer-affiliated treatment billing (Southern Cross Affiliated Provider at select clinics). Go-to-market combines direct consumer acquisition via online booking and phone, enterprise field sales for workplace programs, and channel partnerships with GPs and healthcare providers. MoleMap serves three primary segments: high-risk individuals requiring regular surveillance, corporate workplaces with outdoor or dispersed workforces, and GPs/healthcare providers seeking specialist diagnostic support. The company is privately held with 51-100 employees, has no disclosed external funding rounds beyond a small 2016 Callaghan Innovation grant, and is led by CEO Michelle Aquilina with Chief Medical Officer Dr Lorna Claydon overseeing clinical operations.

Name

MoleMap

Legal name

MoleMap New Zealand

Website

https://molemap.co.nz

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

51–100 employees

Short description

MoleMap is a New Zealand-founded private medical practice specializing in skin cancer detection and monitoring via a triple-check model combining nurse melanographers, proprietary AI, and dermatologist diagnosis, serving high-risk individuals, corporate workplaces, and GP-referred patients across New Zealand and Australia.

Ownership category

akta.pro rank

Product category

Skin Cancer Detection Services

NAICS

Medical and Diagnostic Laboratories (62151)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

General & Medical Dermatology (HLAKACAA)

akta.pro secondary industries

Dermatology Telemedicine Platforms (HLALAGAA), Procedural Dermatology (Office-Based Surgery) (HLAKACAG)

Keywords

• Skin cancer detection
• Dermatology services
• Mole monitoring
• Skin check services
• Dermatologic diagnostics

Headquarters

HQ city

Auckland

HQ country

New Zealand

HQ region

Oceania

Offices19 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Skin Check Services: Professional skin examination services including SkinCheck, SkinCheck+, and Full Body MoleMap. Services include head-to-toe skin checks by melanographers, dermatologist diagnosis, and ongoing monitoring. Pricing varies by service tier and includes consultation, imaging, and specialist review.
2. Skin Cancer Treatment: Treatment services including surgery, topical therapy, and cryotherapy delivered by skin cancer doctors within the clinic network. Southern Cross Affiliated Provider for eligible treatment services at select clinics.
3. Workplace Skin Check Programs: Corporate health programs delivered onsite at workplaces or via voucher programs for employees. Easy to implement for hybrid and dispersed workforces.
4. GP Referral Services: Fast-tracked dermatologist diagnosis for referred patients with comprehensive reports for co-management of patient care.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

MoleMap operates a network of skin cancer detection and monitoring clinics across New Zealand, delivering professional skin examination services through a triple-check model that combines melanographer-led screening, AI-assisted diagnostic analysis against a 30-year image database, and accredited dermatologist diagnosis. The company offers tiered skin check services (Full Body MoleMap, SkinCheck+, and SkinCheck), in-clinic skin cancer treatments, workplace screening programs, and a GP referral pathway for fast-tracked specialist diagnosis.

Product overview

MoleMap is a comprehensive skin cancer detection, diagnosis, and monitoring service provider operating across New Zealand. The core offering is a multi-tiered platform of skin check services: Full Body MoleMap (flagship comprehensive monitoring), SkinCheck+ (with full body imaging), and SkinCheck (point-in-time assessment). All services include melanographer-led examinations, AI-assisted analysis against a 30-year image database, and dermatologist diagnosis. The platform extends to skin cancer treatment, workplace screening programs, and GP referral pathways. The 'triple check' model combines melanographer expertise, AI diagnostic technology, and dermatologist review for enhanced accuracy.

Differentiator

Problem solved

Functional benefit

Products and services

• Full Body MoleMap

Quantifiable outcome

• 95% of melanomas are treatable if detected very early
• +1 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability4 records

Feature4 records

Partnerships

One partnership is on record.

• Eau Thermale AvènecoreGTM or Marketing Partner · 3 December 2024MoleMap partnered with leading skincare brand Eau Thermale Avène in December 2024 to combine MoleMap's expert skin checks with Avène's 30+ years of dermatological expertise in suncare. The collaboration includes joint events such as skin checks at Bondi Beach, sunscreen sampling, and consumer education on skin cancer prevention and detection. Both companies share a commitment to fighting skin cancer in New Zealand through education, detection, and prevention.

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• MoleSafe: MoleSafe offers mole mapping and skin surveillance using dermoscopic imaging and dermatologist review, directly overlapping MoleMap's Full Body MoleMap service in NZ/AU. Highly comparable in clinical workflow, technology stack (total body photography + dermoscopy), and target customer segments.
• MoleCare Skin Cancer Clinic: New Zealand-based skin cancer clinic network providing skin checks, dermoscopy, and skin cancer treatment. Direct overlap with MoleMap on service mix (screening + treatment), geography (NZ), and target audience (high-risk individuals).

Emerging players

• SkinVision: SkinVision provides AI-powered smartphone-based skin cancer risk assessment with dermatologist review. Compares to MoleMap on AI dermatology capability and direct-to-consumer screening intent, though delivered via app rather than in-clinic melanographer visits.
• Skin Analytics: UK-based AI dermatology platform partnering with NHS for melanoma detection using dermoscopic image analysis. Closely comparable AI capability to MoleMap's custom image-database tool, with a health-system distribution model rather than owned clinics.
• First Derm: First Derm is a teledermatology platform offering asynchronous dermatologist review of skin lesion photos. Comparable to MoleMap's melanographer + remote dermatologist workflow, though consumer-app-led rather than clinic-led.
• iDoc24: Teledermatology service providing image-based dermatologist consultations within 24 hours. Overlaps MoleMap's melanographer-captured images → dermatologist-review workflow, focused on consumer-direct skin lesion triage.

Regional players

• National Skin Cancer Centres: Australian network of skin cancer clinics offering full-body skin checks, dermoscopy, and treatment. Closely matches MoleMap's Australia-side offering with a multi-site clinical model in the same target geography.
• Doctor Anywhere: Southeast Asia telehealth platform offering virtual consultations with specialists including dermatologists. Comparable on tele-dermatology delivery model and consumer-pay revenue model, though operating across SEA rather than NZ/AU.

Broad incumbents

• Maple: Canadian telehealth platform providing on-demand access to doctors and specialists, including dermatology consultations. Compares on the telehealth/remote-specialist model MoleMap uses for dermatologist diagnosis, though across a broader primary care scope.
• Teladoc Health: Global telehealth incumbent offering virtual dermatology among other specialties. Compares on tele-dermatology delivery and remote-specialist diagnosis, though at vastly greater scale and as part of a broad virtual care portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/sharer/sharer.php?u=&t=
• Xx.com/MoleMap
• LinkedInlinkedin.com/company/molemap-australia-new-zealand

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MoleMap